Replies to post #200834 on Biotech Values

[DewDiligence]

OPK acquires TTHI for $1.55/sh in stock and cash—a 121% premium based on yesterday’s closing prices:

http://finance.yahoo.com/news/opko-health-acquire-transition-therapeutics-060000772.html

The nominal deal value is $60M.